Related Experiment Videos
Vascular complications of thorium dioxide
The American Journal of Medicine
|June 1, 1978
Summary
Late vascular complications, including stroke and heart attack, occurred in two patients years after thorium dioxide (thorotrast) exposure. These serious health issues highlight the long-term risks associated with this radioactive contrast agent.
Area of Science:
- Vascular Medicine
- Radiology
- Pathology
Background:
- Thorium dioxide (thorotrast) was historically used as a contrast agent in medical imaging.
- Long-term adverse effects of thorotrast exposure, particularly vascular complications, are not fully understood.
- Chronic alpha irradiation from retained thorotrast is a suspected cause of delayed pathology.
Observation:
- Two patients exposed to thorotrast developed severe late-onset vascular complications.
- One patient experienced cerebral and myocardial infarcts, succumbing at age 25.
- The second patient, aged 33, presented with asymptomatic complete right carotid artery obstruction due to a thorotrastoma.
Findings:
- Necropsy revealed significant adventitial and intimal fibrosis of the left carotid artery in the first patient.
- Severe luminal narrowing (over 75%) of the left main and left anterior descending coronary arteries was observed.
- The second patient's necropsy confirmed total obstruction of the right carotid artery attributed to a thorotrastoma.
Implications:
- Thorium dioxide exposure can lead to debilitating and fatal vascular complications years after administration.
- Chronic alpha irradiation from thorotrast is a likely mechanism driving these late vascular events.
- These findings underscore the importance of long-term surveillance for individuals with historical thorotrast exposure.